90 related articles for article (PubMed ID: 12756208)
21. Recent developments in
Yadav J; El Hassani M; Sodhi J; Lauschke VM; Hartman JH; Russell LE
Drug Metab Rev; 2021 May; 53(2):207-233. PubMed ID: 33989099
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment.
Pernaute-Lau L; Adegnika AA; Zhou Y; Zinsou JF; Gil JP; Krishna S; Kremsner PG; Lauschke VM; Velavan TP
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0027521. PubMed ID: 33875422
[TBL] [Abstract][Full Text] [Related]
23. Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates.
Saiz-Rodríguez M; Almenara S; Navares-Gómez M; Ochoa D; Román M; Zubiaur P; Koller D; Santos M; Mejía G; Borobia AM; Rodríguez-Antona C; Abad-Santos F
Biomedicines; 2020 Apr; 8(4):. PubMed ID: 32331352
[TBL] [Abstract][Full Text] [Related]
24. Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.
Schiffer L; Barnard L; Baranowski ES; Gilligan LC; Taylor AE; Arlt W; Shackleton CHL; Storbeck KH
J Steroid Biochem Mol Biol; 2019 Nov; 194():105439. PubMed ID: 31362062
[TBL] [Abstract][Full Text] [Related]
25. Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer.
Buck E; Sprick M; Gaida MM; Grüllich C; Weber TF; Herpel E; Bruckner T; Koschny R
Oncol Lett; 2019 Apr; 17(4):3890-3898. PubMed ID: 30881507
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450 3A Enzymes Are Key Contributors for Hepatic Metabolism of Bufotalin, a Natural Constitute in Chinese Medicine Chansu.
Dai ZR; Ning J; Sun GB; Wang P; Zhang F; Ma HY; Zou LW; Hou J; Wu JJ; Ge GB; Sun XB; Yang L
Front Pharmacol; 2019; 10():52. PubMed ID: 30778299
[TBL] [Abstract][Full Text] [Related]
27. A Xenobiotic Detoxification Pathway through Transcriptional Regulation in Filamentous Fungi.
Sang H; Hulvey JP; Green R; Xu H; Im J; Chang T; Jung G
mBio; 2018 Jul; 9(4):. PubMed ID: 30018104
[TBL] [Abstract][Full Text] [Related]
28. Pazopanib-related tumor lysis syndrome in metastatic clear cell renal cell carcinoma: a case report.
van Kalleveen MW; Walraven M; Hendriks MP
Invest New Drugs; 2018 Jun; 36(3):513-516. PubMed ID: 29464464
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics of Vascular Risk Factors in Alzheimer's Disease.
Cacabelos R; Meyyazhagan A; Carril JC; Cacabelos P; Teijido Ó
J Pers Med; 2018 Jan; 8(1):. PubMed ID: 29301387
[TBL] [Abstract][Full Text] [Related]
30. The X-Ray Crystal Structure of the Human Mono-Oxygenase Cytochrome P450 3A5-Ritonavir Complex Reveals Active Site Differences between P450s 3A4 and 3A5.
Hsu MH; Savas U; Johnson EF
Mol Pharmacol; 2018 Jan; 93(1):14-24. PubMed ID: 29093019
[TBL] [Abstract][Full Text] [Related]
31. Ancestry-Adjusted Vitamin D Metabolite Concentrations in Association With Cytochrome P450 3A Polymorphisms.
Wilson RT; Masters LD; Barnholtz-Sloan JS; Salzberg AC; Hartman TJ
Am J Epidemiol; 2018 Apr; 187(4):754-766. PubMed ID: 28673024
[TBL] [Abstract][Full Text] [Related]
32. Effect of Pregnane X Receptor
Yuan JJ; Ma XJ; Li ZS; Chang YZ; Zhang W; Kan QC; Hou JK; Zhang LR
BMC Med Genet; 2016 Nov; 17(1):87. PubMed ID: 27876007
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenomics of statins: understanding susceptibility to adverse effects.
Kitzmiller JP; Mikulik EB; Dauki AM; Murkherjee C; Luzum JA
Pharmgenomics Pers Med; 2016; 9():97-106. PubMed ID: 27757045
[TBL] [Abstract][Full Text] [Related]
34. Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk.
Oladimeji P; Cui H; Zhang C; Chen T
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):997-1010. PubMed ID: 27295009
[TBL] [Abstract][Full Text] [Related]
35. CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.
Noll EM; Eisen C; Stenzinger A; Espinet E; Muckenhuber A; Klein C; Vogel V; Klaus B; Nadler W; Rösli C; Lutz C; Kulke M; Engelhardt J; Zickgraf FM; Espinosa O; Schlesner M; Jiang X; Kopp-Schneider A; Neuhaus P; Bahra M; Sinn BV; Eils R; Giese NA; Hackert T; Strobel O; Werner J; Büchler MW; Weichert W; Trumpp A; Sprick MR
Nat Med; 2016 Mar; 22(3):278-87. PubMed ID: 26855150
[TBL] [Abstract][Full Text] [Related]
36. Variability in Expression of CYP3A5 in Human Fetal Liver.
Vyhlidal CA; Pearce RE; Gaedigk R; Calamia JC; Shuster DL; Thummel KE; Leeder JS
Drug Metab Dispos; 2015 Aug; 43(8):1286-93. PubMed ID: 25979262
[TBL] [Abstract][Full Text] [Related]
37. Interplay of drug metabolizing enzymes with cellular transporters.
Böhmdorfer M; Maier-Salamon A; Riha J; Brenner S; Höferl M; Jäger W
Wien Med Wochenschr; 2014 Nov; 164(21-22):461-71. PubMed ID: 25271108
[TBL] [Abstract][Full Text] [Related]
38. Hepatic cytochrome P450s play a major role in monocrotaline-induced renal toxicity in mice.
Yao J; Li CG; Gong LK; Feng CC; Li CZ; Gao M; Luan Y; Qi XM; Ren J
Acta Pharmacol Sin; 2014 Feb; 35(2):292-300. PubMed ID: 24362331
[TBL] [Abstract][Full Text] [Related]
39. Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis.
Vuppalanchi R; Liang T; Goswami CP; Nalamasu R; Li L; Jones D; Wei R; Liu W; Sarasani V; Janga SC; Chalasani N
PLoS One; 2013; 8(9):e74471. PubMed ID: 24058572
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.
Godoy P; Hewitt NJ; Albrecht U; Andersen ME; Ansari N; Bhattacharya S; Bode JG; Bolleyn J; Borner C; Böttger J; Braeuning A; Budinsky RA; Burkhardt B; Cameron NR; Camussi G; Cho CS; Choi YJ; Craig Rowlands J; Dahmen U; Damm G; Dirsch O; Donato MT; Dong J; Dooley S; Drasdo D; Eakins R; Ferreira KS; Fonsato V; Fraczek J; Gebhardt R; Gibson A; Glanemann M; Goldring CE; Gómez-Lechón MJ; Groothuis GM; Gustavsson L; Guyot C; Hallifax D; Hammad S; Hayward A; Häussinger D; Hellerbrand C; Hewitt P; Hoehme S; Holzhütter HG; Houston JB; Hrach J; Ito K; Jaeschke H; Keitel V; Kelm JM; Kevin Park B; Kordes C; Kullak-Ublick GA; LeCluyse EL; Lu P; Luebke-Wheeler J; Lutz A; Maltman DJ; Matz-Soja M; McMullen P; Merfort I; Messner S; Meyer C; Mwinyi J; Naisbitt DJ; Nussler AK; Olinga P; Pampaloni F; Pi J; Pluta L; Przyborski SA; Ramachandran A; Rogiers V; Rowe C; Schelcher C; Schmich K; Schwarz M; Singh B; Stelzer EH; Stieger B; Stöber R; Sugiyama Y; Tetta C; Thasler WE; Vanhaecke T; Vinken M; Weiss TS; Widera A; Woods CG; Xu JJ; Yarborough KM; Hengstler JG
Arch Toxicol; 2013 Aug; 87(8):1315-530. PubMed ID: 23974980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
